ciprofloxacin has been researched along with ceragenin csa-13 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt-Guzel, C; Gerceker, AA; Savage, PB | 1 |
| Akcali, A; Bozkurt-Guzel, C; Ozbek-Celik, B; Savage, PB | 1 |
2 other study(ies) available for ciprofloxacin and ceragenin csa-13
| Article | Year |
|---|---|
In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Topics: Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Steroids; Tobramycin | 2011 |
Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients.
Topics: Acinetobacter baumannii; Carbapenems; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Steroids | 2014 |